Related Experiment Video

Updated: Apr 4, 2026

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

1.0K

Correction: Endothelial Expression of Endothelin Receptor A in the Systemic Capillary Leak Syndrome

Albert C Sek, Zhihui Xie, Kaoru Terai

    Plos One
    |September 2, 2015
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay08:43

    Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay

    Published on: June 19, 2018

    16.1K
    An in vivo Assay to Test Blood Vessel Permeability07:03

    An in vivo Assay to Test Blood Vessel Permeability

    Published on: March 16, 2013

    67.3K

    Related Concept Videos

    Regulation of Angiogenesis and Blood Supply01:24

    Regulation of Angiogenesis and Blood Supply

    Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
    4.0K
    Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

    Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

    Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
    ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
    564